AMICUS THERAPEUTICS, INC. Quarterly Operating Margin in % from Q4 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Amicus Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2021 to Q2 2024.
  • Amicus Therapeutics, Inc. Operating Margin for the quarter ending June 30, 2024 was -7.35 %, a 80.6% increase year-over-year.
  • Amicus Therapeutics, Inc. annual Operating Margin for 2023 was -19.3 %, a 70% increase from 2022.
  • Amicus Therapeutics, Inc. annual Operating Margin for 2022 was -64.4 %, a 4.65% increase from 2021.
  • Amicus Therapeutics, Inc. annual Operating Margin for 2021 was -67.6 %, a 28.6% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -7.35 +30.5 +80.6% Apr 1, 2024 Jun 30, 2024
Q1 2024 -15.9 +35.9 +69.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -19.3 +45.1 +70% Oct 1, 2023 Dec 31, 2023
Q3 2023 -31.1 +43.7 +58.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -37.8 +40.2 +51.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 -51.8 +20.2 +28% Jan 1, 2023 Mar 31, 2023
Q4 2022 -64.4 +3.14 +4.65% Oct 1, 2022 Dec 31, 2022
Q3 2022 -74.8 Jul 1, 2022 Sep 30, 2022
Q2 2022 -78 Apr 1, 2022 Jun 30, 2022
Q1 2022 -72 Jan 1, 2022 Mar 31, 2022
Q4 2021 -67.6 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.